Patterns and predictors of substance use disorders and daily tobacco use in first-episode psychosis

Australian and New Zealand Journal of Psychiatry

Volumn 39, Issue 10, 2005, Pages 892-898

  Wade, Darryl ^a   Harrigan, Susy ^a   Edwards, Jane ^a   Burgess, Philip M ^b   Whelan, Greg ^a   McGorry, Patrick D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

First episode; Psychosis; Schizophrenia; Substance abuse; Tobacco use

Indexed keywords

ALCOHOL; AMPHETAMINE; BENZODIAZEPINE; CANNABIS; OPIATE; PSYCHEDELIC AGENT;

ADOLESCENT; ADULT; AGE; ARTICLE; AUSTRALIA; CLINICAL ASSESSMENT; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DRUG ABUSE PATTERN; FEMALE; HOSPITALIZATION; HUMAN; INHALANT ABUSE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ONSET AGE; PREDICTION; PSYCHOSIS; RATING SCALE; RELIABILITY; RISK FACTOR; SCHIZOPHRENIA; SEX DIFFERENCE; SUBSTANCE ABUSE; SYMPTOMATOLOGY; TOBACCO DEPENDENCE; UNEMPLOYMENT; ADDICTION; COMORBIDITY; EDUCATIONAL STATUS; EMPLOYMENT; PREDICTION AND FORECASTING; PSYCHOLOGICAL ASPECT; RISK; SMOKING; TIME;

ADOLESCENT; ADULT; AGE FACTORS; AUSTRALIA; COMORBIDITY; EDUCATIONAL STATUS; EMPLOYMENT; FEMALE; HUMANS; MALE; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PSYCHOTIC DISORDERS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SMOKING; SUBSTANCE-RELATED DISORDERS; TIME FACTORS;

EID: 33644876650     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1111/j.1440-1614.2005.01699.x     Document Type: Article

References (24)

1. Drake RE, Brunette MF. Complications of severe mental illness related to alcohol and drug use disorders. In: Galanter M, ed. Recent developments in alcoholism, volume 14: The consequences of alcoholism. New York: Plenum, 1998:285-299.
2. Ram R, Bromet EJ, Eaton WW, Pato C, Schwartz JE. The natural course of schizophrenia: A review of first-admission studies. Schizophrenia Bulletin 1992; 18:185-207.
3. Edwards J, Hinton M, Elkins K, Athanasopoulos A. Cannabis and first-episode psychosis: The CAP project. In: Graham H, Mueser KT, Birchwood M, Copello A, eds. Substance misuse in psychosis: Approaches to treatment and service delivery. Chichester: Wiley, 2003:283-304.
4. Verma SK, Subramaniam M, Chong S, Kua EH. Substance abuse in schizophrenia: A Singapore perspective. Social Psychiatry and Psychiatric Epidemiology 2002; 37:326-328.
5. Rabinowitz J, Bromet EJ, Carlson LG, Kovasznay B, Schwartz JE. Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients. Psychological Medicine 1998; 28:1411-1419.
6. Hambrecht M, Hafner H. Substance abuse and the onset of schizophrenia. Biological Psychiatry 1996; 40:1155-1163.
7. Sevy S, Robinson DG, Solloway S et al. Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder. Acta Psychiatric Scandinavica 2001; 104:367-374.
8. Cantwell R, Brewin J, Glazebrook C et al. Prevalence of substance misuse in first-episode psychosis. British Journal of Psychiatry 1999; 174:150-153.
9. Linszen DH, Dingemans PM, Lenior ME. Cannabis abuse and the course of recent-onset schizophrenic disorders. Archives of General Psychiatry 1994; 51:273-279.
10. McGorry PD, Singh BS, Copolov DL, Kaplan I, Dossetor CR, van Riel RJ. Royal Park Multidiagnostic Instrument for Psychosis: Part II: development, reliability, and validity. Schizophrenia Bulletin 1990; 16:517-536.
11. McGovern MP, Morrison DH. The Chemical Use, Abuse, and Dependence scale (CUAD): Rationale, reliability, and validity. Journal of Substance Abuse Treatment 1992; 9:27-38.
12. Kavanagh DJ, Waghorn G, Jenner L et al. Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample. Schizophrenia Research 2004; 66:115-124.
13. Cannon-Spoor HE, Potkin SG, Wyatt RJ. Measurement of premorbid adjustment in chronic schizophrenia. Schizophrenia Bulletin 1982; 8:470-484.
14. Lukoff D, Liberman RP, Nuechterlein KH. Symptom monitoring in the rehabilitation of schizophrenic patients. Schizophrenia Bulletin 1986; 12:578-602.
15. Andreasen NC. Scale for the Assessment of Negative Symptoms (SANS). Iowa City: University of Iowa, 1981.
16. Hall W, Teesson M, Lynskey M, Degenhardt L. The 12-month prevalence of substance use and ICD-10 substance use disorders in Australian adults: findings from the National Survey of Mental Health and Well-Being. Addiction 1999; 94:1541-1550.
17. Blanchard JJ, Brown SA, Horan WP, Sherwood AR. Substance use disorders in schizophrenia: Review, integration, and a proposed model. Clinical Psychology Review 2000; 20:207-234.
18. Conus P, Lambert M, Eide P et al. First episode outcome study (FEPOS study). Schizophrenia Research 2004; 67 (Suppl): 196.
19. Van Mastrigt S, Addington J, Addington D. Substance misuse at presentation to an early psychosis program. Social Psychiatry and Psychiatric Epidemiology 2004; 39:69-72.
20. Morral AR, McCaffrey DF, Paddock SM. Reassessing the marijuana gateway effect. Addiction 2002; 97:1493-1504.
21. Arseneault L, Cannon M, Witton J, Murray RM. Causal association between cannabis and psychosis: Examination of the evidence. British Journal of Psychiatry 2004; 184:110-117.
22. Greenfield SF, Manwani SG, Nargiso JE. Epidemiology of substance use disorders in women. Obstetrics and Gynecology Clinics of North America 2003; 30:413-446.
23. Arndt S, Tyrrell G, Flaum M, Andreasen NC. Comorbidity of substance abuse and schizophrenia: The role of premorbid adjustment. Psychological Medicine 1992; 22:379-388.
24. Escobedo LG, Peddicord JP. Smoking prevalence in US birth cohorts: The influence of gender and education. American Journal of Public Health 1996; 86:231-236.